Mobia Medical, Inc. MOBI

Annual Quarterly

Q3 FY2026 · ended Sep 30, 2026 · Revenue $15.62M, +15.6% YoY · Filed Nov 5, 2026

Mobia Medical, Inc. (MOBI) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $15.6 million and a net loss of $17.3 million. Free cash flow was -$13.0 million. As of Sep 30, 2026 it held $160.7 million in cash and investments and $1.1 million in total debt.

Revenue
$15.62M
+15.6% vs prior quarter
Net income
$-17.34M
+17.6% vs prior quarter
Operating cash flow
$-12.92M
+17.5% vs prior quarter
Free cash flow
$-12.98M
+24.6% vs prior quarter
EPS
$-0.52
+52.7% vs prior quarter
Dividend per share
None
Shares outstanding
33.33M
+0.1% vs prior quarter
Net cash
$159.63M
Q3 FY2026
Operating margin
-118.7%
Q3 FY2026

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
MOBI (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Austin, TX
SEC filer status
, Emerging growth company
SEC CIK
1489993
Former names
MicroTransponder, Inc. (until Jan 21, 2026)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Revenue
$15.6M
$13.5M
$12.1M
Operating income
-$18.5M
-$17.9M
-$16.9M
Net income
-$17.3M
-$21.0M
-$17.7M
Diluted EPS
-$0.52
-$1.10
-$19.30
Operating cash flow
-$12.9M
-$15.7M
-$17.7M
Free cash flow
-$13.0M
-$17.2M
-$17.8M
Total assets
$181.2M
$195.3M
$73.6M
Total liabilities
$23.3M
$22.7M
$61.6M
Stockholders' equity
$157.9M
$172.6M
-$167.7M
Cash and investments
$160.7M
$177.1M
$55.7M
Total debt
$1.1M
$1.1M
$1.2M

Recent SEC filings

Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
 Nov 5, 2026 Nov 5, 2026
8-K/A Amended current report
Officer or director change
 Oct 16, 2026 Jul 30, 2026
8-K/A Amended current report
Officer or director change
 Oct 16, 2026 Jul 14, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Results of operations
 Aug 11, 2026 Aug 11, 2026

All 84 Mobia Medical, Inc. SEC filings

Source: SEC EDGAR filings. This is company-reported data, not investment advice.